Understanding Gut Leakage in Dengue Fever
Part of Digestive system, Infections clinical trials.
This study investigates whether dengue fever causes the intestinal lining to become leaky, allowing harmful substances to enter the bloodstream. Researchers compare blood markers in dengue patients and healthy volunteers to understand how this happens and why it might make dengue worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- For dengue patients: hospitalized within the last 24 hours with confirmed dengue (positive NS1 antigen or IgM antibody test)
- For healthy volunteers: be a family member or attendant of a dengue patient with no current illness
- No chronic gut, liver, or heart conditions that affect how your intestines work
- Have not taken metformin, statins, probiotics, or steroids in the 48 hours before enrollment
- Not pregnant, not immunosuppressed (no chemotherapy or high-dose steroids), and no advanced kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
This study follows patients hospitalised with dengue to better understand the disease and improve future research. If you are in the hospital with confirmed dengue, you may be eligible to join.
This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.
This study tests a controlled dengue infection in volunteers who already have immunity to some dengue types. It aims to see how safe it is and how the immune system responds, which could help develop better vaccines.
This study looks at how the immune system responds to dengue, flu, and sepsis. It may help doctors understand these illnesses better and improve future treatments.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.